Wealth Enhancement Advisory Services’s Ironwood Pharmaceuticals IRWD Stock Holding History
Bought
Maintained
Sold
Other funds holding IRWD
WCM
CAMG
MFG
NAM
RFG
TWD
GI
CA
DWM
RDFA
Wealth Enhancement Advisory Services's IRWD Position: Q2 2026 in Review
Wealth Enhancement Advisory Services reduced its Ironwood Pharmaceuticals (IRWD) stake by 3.2% in Q2 2026, selling an estimated $27.9K and leaving 219,445 shares worth $913K. The position accounts for ﹤0.01% of the portfolio, ranked #2139.
Wealth Enhancement Advisory Services first reported a position in IRWD in Q2 2024 and has held it in 8 quarters since. 11 funds tracked by Wall St. Rank hold IRWD as of Q2 2026.
- Wealth Enhancement Advisory Services held 219,445 shares of Ironwood Pharmaceuticals worth $913K as of Q2 2026.
- Wealth Enhancement Advisory Services sold 7,243 Ironwood Pharmaceuticals shares in Q2 2026, an estimated $27.9K.
- Ironwood Pharmaceuticals made up ﹤0.01% of Wealth Enhancement Advisory Services's portfolio in Q2 2026, its #2139 holding.
- Wealth Enhancement Advisory Services first reported a position in Ironwood Pharmaceuticals in Q2 2024 and has held it in 8 quarters since.
- 11 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q2 2026.
Based on Wealth Enhancement Advisory Services's 13F filing for Q2 2026, filed 15 Jul 2026.